Characterising inflammatory and malignant skin diseases

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00038243

Enrollment

Registered

2025-11-04

Start date

2023-03-02

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

L40.0 L20.8 C84.0 C84.1 C82.6 C83.9 C83.3 C86.6

Interventions

Group 1: Patients with inflammatory and clinically overlapping malignant skin diseases The study investigates whether the use of novel 'omics technologies and machine learning models can improve the

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of one of the listed diseases

Exclusion criteria

Exclusion criteria: Pregnancy

Design outcomes

Primary

Measure	Time frame
Identification of 'omics based markers to support to diagnoses and differentiation of these diseases	—

Secondary

Measure	Time frame
Identification of 'omics based markers to predict therapy response	—

Countries

Austria

Contacts

Public ContactJohannes Griss

Medizinische Universität Wien

johannes.griss@meduniwien.ac.at+43 1 40400 77020

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026